Table 2.
Clinical outcomes after treatment for cesarean scar defect
| Variable | Adenomyosis group (n = 50) | Non-adenomyosis group (n = 228) | P value |
|---|---|---|---|
| Hemoglobin on the first postoperative day (g/L) | 99.5 ± 13.4 (74.2–125.0) | 106.0 ± 11.2 (77.2–134.0) | 0.012 |
| Blood loss during operation (ml) | 31.8 ± 20.0 (10–100) | 30.8 ± 23.6 (10–200) | 0.745 |
| Duration of surgical procedure (min) | 57.0 ± 11.8 (30–90) | 55.9 ± 9.4 (25–99) | 0.497 |
| Length of hospital stay (d) | 7.0 (1.0) | 6.5 (1.0) | 0.296** |
| Hospitalization cost (CNY) | 10,870 (2175.3) | 11,085.0(1997.3) | 0.528** |
| Complications (n) | |||
| Bladder injury | 0 (0.0%) | 2 (.9%) | 0.672* |
| Hematoma | 1 (2.0%) | 2 (.9%) | 0.450* |
Data presented as mean ± SD (range) except for complications, length of hospital stay and hospitalization cost, where complications presented as numbers (percentage) and length of hospital stay and hospitalization cost presented as median (interquartile range)
* Fisher’s Exact Test was used. ** Mann-Whitney U Test was used